Brødkrumme Forside Vesper Biotechnology Vesper Biotechnology Vesper Technology is a preclinical biotech company developing treatments based on Vps10p-protein to target various therapeutic indications. Relateret nyheder om Vesper Biotechnology Lundbeckfonden fordobler sin investering i aarhusianske Insusense Therapeutics Lundbeckfonden BioCapital Investeringsår 2012 Seed Financing Lokation Aarhus, Denmark Investors Lundbeckfonden BioCapital Kontakt Paul Little Operating Partner pl@lundbeckfonden.com Kevin Dalgaard Principal kdd@lundbeckfonden.com Mobil +45 3013 5365